Search
Abivax SA
ABVXAdd to Watchlist
144.650USD
+12.090+9.12%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
12
analysts
Buy
Current Rating
148.923
Target Price
+12.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Abivax SA
ABVX
12
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
FAQs
What is the analyst rating for Abivax SA?
Based on the ratings of Abivax SA's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.